Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-20-014217
Filing Date
2020-12-07
Accepted
2020-12-07 16:01:35
Documents
11
Period of Report
2021-01-27
Effectiveness Date
2020-12-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20210127xdef14a.htm DEF 14A 2819712
2 GRAPHIC tmb-20210127xdef14a013.jpg GRAPHIC 20864
3 GRAPHIC tmb-20210127xdef14a011.jpg GRAPHIC 32602
4 GRAPHIC tmb-20210127xdef14a007.jpg GRAPHIC 76046
5 GRAPHIC tmb-20210127xdef14a019.jpg GRAPHIC 105214
6 GRAPHIC tmb-20210127xdef14a010.jpg GRAPHIC 57193
7 GRAPHIC tmb-20210127xdef14a001.jpg GRAPHIC 10355
8 GRAPHIC tmb-20210127xdef14a009.jpg GRAPHIC 50124
9 GRAPHIC tmb-20210127xdef14a020.jpg GRAPHIC 103272
10 GRAPHIC tmb-20210127xdef14a002.jpg GRAPHIC 9444
11 GRAPHIC tmb-20210127xdef14a012.jpg GRAPHIC 37537
  Complete submission text file 0001558370-20-014217.txt   3514424
Mailing Address 9000 STATE ROAD 9000 STATE ROAD PHLADELPHIA PA 19136
Business Address 9000 STATE RD PHILADELPHIA PA 19136 2153339000
LANNETT CO INC (Filer) CIK: 0000057725 (see all company filings)

EIN.: 230787699 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-31298 | Film No.: 201372724
SIC: 2834 Pharmaceutical Preparations